TipRanks
Advertisement
Advertisement
Merck KGaA to acquire Silence Therapeutics for $20 per ADS in cash
PremiumThe FlyMerck KGaA to acquire Silence Therapeutics for $20 per ADS in cash
16h ago
Merck KGaA to acquire Silence Therapeutics for $20 per ADS in cash
Premium
The Fly
Merck KGaA to acquire Silence Therapeutics for $20 per ADS in cash
16h ago
Silence Therapeutics 13M share Secondary priced at $13.50
Premium
The Fly
Silence Therapeutics 13M share Secondary priced at $13.50
2M ago
Silence Therapeutics files to sell $150M in ADS’s
PremiumThe FlySilence Therapeutics files to sell $150M in ADS’s
2M ago
Silence Therapeutics Reports Positive Phase 2 Divesiran Data
Premium
Company Announcements
Silence Therapeutics Reports Positive Phase 2 Divesiran Data
2M ago
Silence announces results from Phase 2 SANRECO trial met primary endpoint
Premium
The Fly
Silence announces results from Phase 2 SANRECO trial met primary endpoint
2M ago
Cantor starts ‘materially undervalued’ Silence Therapeutics at Overweight
PremiumThe FlyCantor starts ‘materially undervalued’ Silence Therapeutics at Overweight
4M ago
Silence Therapeutics initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
Silence Therapeutics initiated with an Overweight at Cantor Fitzgerald
4M ago
Silence Therapeutics Updates Strategy and siRNA Pipeline
Premium
Company Announcements
Silence Therapeutics Updates Strategy and siRNA Pipeline
4M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―